That study proposed a model for cardiovascular disease, in which increased atherosclerosis risk is associated with increased linear ANRIL; linear ANRIL epigenetically regulates factors that promote cell adhesion and proliferation by acting as a molecular scaffold for the polycomb repressive complex (PRC1/2). This evidence concerns the gene PRC1 and atherosclerosis.